| Effect of feeding a formula supplemented with long-chain polyunsaturated fatty acids for 14 weeks improves the ex vivo response to a mitogen and reduces the response to a soy protein in infants at low risk for allergy. | |
| | |
MedLine Citation:
|
PMID: 20386325 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND OBJECTIVE: Feeding long-chain polyunsaturated fatty acids (LCP) influences immunity in adults; however, less is known about their effect during development. The aim of the study was to determine the effect of feeding LCP on immunity in healthy infants during the first 4 months of life. PATIENTS AND METHODS: Formula-fed infants were randomized at <or=14 days of age to standard term formula (Formula) or formula containing LCP (Formula+LCP). Infants exclusively fed human milk (HM) were included for comparison. At 16 weeks of age, blood was collected and phenotypes, the ability to proliferate and produce cytokines (interleukin [IL]-2, IL-4, IL-6, IL-10, IL-12, interferon [IFN]-gamma, tumor necrosis factor [TNF]-alpha, TGF-beta) after incubation with phytohemaglutinin (PHA), beta-lactoglobulin, or soy protein were measured. RESULTS: Feeding LCP resulted in a higher than and more similar proliferation rate to PHA in HM-fed infants, possibly because of a greater TH1 type cytokine response and a higher percentage of antigen mature (CD45RO+) cells (P < 0.05). The response to beta-lactoglobulin did not differ among groups. After incubation with soy protein Formula+LCP, compared with Formula produced less IL-2 and more TNF-alpha and had a higher percentage of CD8+ and a lower percentage of CD20+ (CD20+CD54+) cells poststimulation (P < 0.05). Both formula groups produced less IL-2 after PHA, had a lower percentage of CD80+ cells, and a higher percentage of CD54+ cells after incubation with food proteins (P < 0.05). CONCLUSIONS: Formula-fed infants, at low risk for allergy, respond differently to mitogen and food proteins ex vivo than those fed HM. Feeding LCP altered some of these differences in the direction that is hypothesized to confer immune benefits. |
| | |
Authors:
|
Catherine J Field; John E Van Aerde; Susan Goruk; M Thomas Clandinin |
Related Documents
:
|
16469455 - Vegetable acceptance by infants: effects of formula flavors. 10443505 - The protective effect of breast feeding in relation to sudden infant death syndrome (si... 9646215 - Use of a new thickened formula for treatment of symptomatic gastrooesophageal reflux in... 17229535 - The effect of a bifidobacter supplemented bovine milk on intestinal permeability of pre... 20607645 - Swallow-breath interaction and phase of respiration with swallow during nonnutritive su... 17473095 - Maternal antibodies in breast milk protect the child from enterovirus infections. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of pediatric gastroenterology and nutrition Volume: 50 ISSN: 1536-4801 ISO Abbreviation: J. Pediatr. Gastroenterol. Nutr. Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-26 Completed Date: 2010-11-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8211545 Medline TA: J Pediatr Gastroenterol Nutr Country: United States |
Other Details:
|
Languages: eng Pagination: 661-9 Citation Subset: IM |
Affiliation:
|
Department of Agricultural, Food, and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada. Catherine.field@ualberta.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antigens
/
metabolism Cell Proliferation / drug effects Cells, Cultured Dietary Proteins / adverse effects* Dietary Supplements Docosahexaenoic Acids / pharmacology Fatty Acids, Unsaturated / pharmacology* Female Food Hypersensitivity Humans Immunity, Innate / drug effects* Infant Infant Formula Infant, Newborn Interleukin-2 / blood Leukocytes, Mononuclear / drug effects* Male Mitogens / adverse effects* Plant Lectins / adverse effects* Soybean Proteins / adverse effects* Tumor Necrosis Factor-alpha / blood alpha-Linolenic Acid / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Antigens; 0/Dietary Proteins; 0/Fatty Acids, Unsaturated; 0/Interleukin-2; 0/Mitogens; 0/Plant Lectins; 0/Soybean Proteins; 0/Tumor Necrosis Factor-alpha; 25167-62-8/Docosahexaenoic Acids; 463-40-1/alpha-Linolenic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antioxidant properties of breast milk in a novel in vitro digestion/enterocyte model.
Next Document: Abdominal tuberculosis in children.